BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 805973)

  • 1. [Proceedings: Differentiation of homozygote and heterozygote, therapy and follow-up study in 4 families with Wilson's disease].
    Abendschein Th; Przuntek H; Wesch H; Gäng V
    MMW Munch Med Wochenschr; 1975 May; 117(20):842. PubMed ID: 805973
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetics of radioactive copper in Wilson's disease].
    Willvonseder R; Goldstein NP; Tauxe WN
    Wien Z Inn Med; 1973; 54(5):226-33. PubMed ID: 4790777
    [No Abstract]   [Full Text] [Related]  

  • 3. Observations on copper metabolism in Wilson's disease.
    Czlonkowska A; Galewicz A; Rodo M; Wehr H
    Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768
    [No Abstract]   [Full Text] [Related]  

  • 4. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The liver-thigh 64Cu ratio in Wilson's disease.
    Levi AJ; Williams HS
    Clin Sci; 1968 Apr; 34(2):379-83. PubMed ID: 5690128
    [No Abstract]   [Full Text] [Related]  

  • 6. [Early symptoms and early diagnosis in Wilson's disease].
    Przuntek H; Wesch H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():678-80. PubMed ID: 1029259
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolution of the hepatic lesion in Wilson's disease (hepatolenticular degeneration).
    Sternlieb I
    Prog Liver Dis; 1972; 4():511-25. PubMed ID: 4569009
    [No Abstract]   [Full Text] [Related]  

  • 8. [Radioactive copper in the diagnosis of Wilson's disease].
    Czlonkowska A; Wehr H; Galewicz A; Harmak E; Rodo M; Wald I
    Pol Tyg Lek; 1973 May; 28(17):597-9. PubMed ID: 4712325
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of the heterozygote of Wilson's disease.
    O'Reilly S; Weber P; Pollycove M; Shipley L
    J Nucl Med; 1969 Mar; 10(3):143-4. PubMed ID: 5785018
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term body retention of radiocopper (67Cu) and the diagnosis of Wilson's disease.
    Willvonseder R; Goldstein NP; Tauxe WN
    Mayo Clin Proc; 1974 Jun; 49(6):387-93. PubMed ID: 4835809
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early diagnosis and prevention of Wilson's disease].
    Arima M
    Saishin Igaku; 1969 Jun; 24(6):1219-25. PubMed ID: 5805577
    [No Abstract]   [Full Text] [Related]  

  • 12. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of liver enzymes, serum ceruloplasmin and urine copper in parents of children with Wilson's disease.
    Haghighat M; Dehghani SM; Imanieh MH; Gholami S
    Saudi Med J; 2008 Jul; 29(7):1056-7. PubMed ID: 18626543
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening asymptomatic family members for Wilson's disease.
    Lindahl JA; Sharp HL
    Minn Med; 1982 Aug; 65(8):473-5. PubMed ID: 6752690
    [No Abstract]   [Full Text] [Related]  

  • 15. Wilson's disease: diagnostic difficulties in the patient with chronic hepatitis and hypoceruloplasminemia.
    Spechler SJ; Koff RS
    Gastroenterology; 1980 Apr; 78(4):803-6. PubMed ID: 7353765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilson's disease patients with normal ceruloplasmin levels.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heterozygote test using 64 Cu in Wilson's disease].
    Günther K; Biesold D; Lössner J; Löbe J
    Radiol Diagn (Berl); 1975; 16(1):61-8. PubMed ID: 1197691
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of whole-body counter to study body retention of radiocopper in Wilson's disease.
    Hamamoto K; Tauxe WN; Novak LP; Goldstein NP
    J Lab Clin Med; 1968 Nov; 72(5):754-9. PubMed ID: 5697385
    [No Abstract]   [Full Text] [Related]  

  • 19. Turnover studies of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu.
    Strickland GT; Beckner WM; Leu ML; O'Reilly S
    Clin Sci; 1972 Nov; 43(5):605-15. PubMed ID: 5083936
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical and clinical changes in Wilson's disease heterozygotes.
    Marecek Z; Nevsímalová S
    J Inherit Metab Dis; 1984; 7(1):41-5. PubMed ID: 6429441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.